| |
Glycosmedia
- weekly publication |
| |
Due to a lack of funding Glycosmedia will now
be published weekly. If we can raise sufficient income we will
revert back to a daily publication. We would welcome offers of
advertising, sponsorship or educational grants. Please contact
us for information (Editor) |
| |
|
 |
Recombinant
interferon-alpha may delay onset of type 1 diabetes in young
patients |
| |
Young patients with type 1 diabetes assigned
to low doses of human recombinant interferon-alpha treatment maintained
more beta-cell function one year following study enrollment when
compared with placebo-matched controls (Endocrine Today) |
| |
|
|
BG
Levels Nearly Normal When Liver Enzyme Suppressed in Research |
| |
By inhibiting the expression of a gene called
sirtuin 1, Yale researchers have been able to reduce blood glucose
levels, decrease the liver's production of glucose, and increase
insulin sensitivity in rats conditioned to exhibit type 2 symptoms
(Diabetes Health) |
| |
|
|
Novo
Nordisk wins Europe OK for diabetes drug |
| |
Novo Nordisk said the European Commission has
granted marketing authorisation for Victoza, or liraglutide, for
the treatment of type 2 diabetes in adults (Market Watch) |
| |
|
|
Inconclusive
research links glargine insulin (Lantus) with cancer |
| |
Diabetes UK has today cautioned that research
claiming there is a link between certain insulins and some cancers
is “inconclusive” (Diabetes UK) |
| |
|
|
Canadian
Diabetes Association Statement on Insulin Glargine and the Possible
Link to Cancer |
| |
At this time, the Canadian Diabetes Association
believes there is insufficient evidence to conclude that there
is an increased risk of cancer with the use of insulin glargine
(Canadian Diabetes Association) |
| |
|
|
'Jumping
Gene' Diminishes The Effect Of New Type 2 Diabetes Risk Gene |
| |
Research led by the German Institute of Human
Nutrition has identified a new gene associated with diabetes, together
with a mechanism that makes obese mice less susceptible to diabetes
(Science Daily) |
| |
|
|
Diabetes
risk high in children with persistent metabolic syndrome |
| |
Children with persistent metabolic syndrome
have accelerated fat gain, increased insulin response to oral glucose,
and decreased insulin sensitivity and beta-cell function, all indicators
of progressively greater risk for Type 2 diabetes, researchers
show (MedWire News) |
| |
|
|
Megatrials
in type 2 diabetes. From excitement to frustration? |
| |
Results, however, require some reconciliation,
and the objective of this commentary is to analyse a series of
elements, including the changes in the treatment approach to CV
risk factors in type 2 diabetes, the effect of glucose-lowering
agents, and the characteristics of the patients included in the
different trials (Diabetologia) |
| |
|
|
Over
2 billion used needles end up in trash each year |
| |
Six million are people with medical conditions
that require injections. The other three million are intravenous
drug users (Examiner, USA) |
| |
|
